Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Liabilities and Shareholders Equity (2016 - 2025)

Healthy Extracts filings provide 11 years of Liabilities and Shareholders Equity readings, the most recent being $27.8 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 1070.1% to $27.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $58.9 million, a 493.07% increase, with the full-year FY2025 number at $27.8 million, up 1070.1% from a year prior.
  • Liabilities and Shareholders Equity hit $27.8 million in Q4 2025 for Healthy Extracts, up from $26.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $27.8 million in Q4 2025 to a low of $2.4 million in Q4 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $2.8 million (2022), compared with a mean of $5.2 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: dropped 22.78% in 2021 and later skyrocketed 1070.1% in 2025.
  • Healthy Extracts' Liabilities and Shareholders Equity stood at $3.0 million in 2021, then fell by 8.2% to $2.8 million in 2022, then decreased by 5.25% to $2.6 million in 2023, then fell by 9.75% to $2.4 million in 2024, then skyrocketed by 1070.1% to $27.8 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $27.8 million (Q4 2025), $26.2 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.